Literature DB >> 12036131

Visible absorption spectra of the 4f electron transitions of neodymium, praseodymium, holmium and erbium complexes with fleroxacin and their analytical application.

Naixing Wang1, Wei Jiang, Xiuqin Xu, Zhikun Si, Haitao Bai, Cong Tian.   

Abstract

The absorption spectra of the 4f electron transitions of neodymium, praseodymium, holmium and erbium complexes with fleroxacin in the presence of cetylpyridinium chloride were studied by normal and derivative spectrophotometry. Their molar absorptivity at the maximum absorption bands are about 5.3 (at 571 nm) times greater for neodymium, 2.8 (at 483 nm) times greater for praseodymium, 12.6 (at 448.5 nm) times greater for holmium and 9.7 (at 519 nm) times greater for erbium than those in the absence of complexing agents. The second-derivative spectrum is used both to eliminate the interference from other rare earths and to improve the sensitivity. Beer's law is obeyed from 3.0 - 70 microg ml(-1) for neodymium and holmium, from 6.0 - 70 microg ml(-1) for erbium, and from 12.0 - 70 microg ml(-1) for praseodymium. The relative standard deviations are 1.9% and 1.5% for 7.5 microg ml(-1) of neodymium and holmium, and 2.1% and 1.6% for 15.0 microg ml(-1) of praseodymium and erbium, respectively. Their detection limits (signal-to-noise ratio = 2) are 3.2 microg ml(-1), 1.3 microg ml(-1), (1.1) microg ml(-1) and 2.5 microg ml(-1) for praseodymium, neodymium, holmium and erbium, respectively. A new system for the simultaneous determinations of the praseodymium, neodymium, holmium and erbium in rare earth mixtures with good accuracy and selectivity is proposed.

Entities:  

Year:  2002        PMID: 12036131     DOI: 10.2116/analsci.18.591

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   2.081


  1 in total

1.  A study on enhancing the quantum yield and antimicrobial activity of Pr(iii) by varying the coordination environment.

Authors:  Iffat Ameen; Abhishek Kumar Tripathi; Raj Laxmi Mishra; Afshan Siddiqui; Umesh Nath Tripathi
Journal:  RSC Adv       Date:  2018-02-22       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.